Trial intelligence / Profile preview

Free influenza vaccination at discharge for hospitalized heart failure patients

ChiCTR2100053264Phase 4Recruiting

Sponsor
Heart Health Research Center
Start
Dec 2021
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, randomised, open-label trial of influenza vaccine in heart failure (HF) (2 arms), sponsored by Heart Health Research Center. Primary endpoint: Composite of all-cause death and all-cause hospitalization at 1 year. Started Dec 2021; status: recruiting.

02

Drugs

influenza vaccine
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on ChiCTR2100053264.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100053264.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call